La cadena de opciones muestra datos clave de las opciones de acciones de Lifecore Biomedical a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Lifecore Biomedical..

Lifecore Biomedical (NASDAQ:LFCR) Bolsa, Cadena de Opciones

Lifecore Biomedical

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

LFCR

SPSC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: WGS, LFCR, SPSC, RGP y UDR.

5 acciones en el foco este viernes: WGS, LFCR, SPSC, RGP y UDR

XPEV

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este jueves: RGP, NIO, LFCR, LI y XPEV.

5 acciones en el foco este jueves: RGP, NIO, LFCR, LI y XPEV

Lifecore Biomedical Inc

Biotech

Management

Press Releases

General

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Financing

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Contracts

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Legal

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Atlantic International Corp. - Common Stock

Atlantic International

BioLife Solutions

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

ImmunoPrecise Antibodies Ltd. - Common Stock

ImmunoPrecise Antibodies

Standard BioTools

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Stephens & Co.

Craig-Hallum

Comments

Lifecore Biomedical

Lifecore Biomedical (LFCR) Opciones

Lifecore Biomedical (NASDAQ:LFCR) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL